Identify the barriers contributing to the geographic and racial healthcare disparities in cardiac amyloidosis (ATTR-CM) care.

The 60-minute CME-certified activity, “Rationale and Evidence for Individualized Treatment Decisions in gMG,” will review recently approved and emerging treatment options.

This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the forearm and hand including pattern recognition, scanning tips, and needle guidance techniques.

Develop more culturally conscious clinical and communication-based skills to better assess and address the needs of minority patients with Multiple Sclerosis (MS).

 Assess the role of potential biomarkers and other key indicators of multiple sclerosis (MS) related to early diagnosis of MS 

Archive from the live ACMG symposium including original infographics, FAQs from the live symposium, suggested readings, and access to available guidelines/recommendations. 

Describe the latest research being presented to better manage MPS II and its clinical relevance.

Assess modalities that facilitate the early diagnosis of NMOSD.